Home / Letter From The Editor (page 110)

Letter From The Editor

GLP-1 Special Series Editor’s Note #7

There’s been some interesting research on a compound that appears to be a partner peptide for GLP-1. Oxyntomodulin is released in response to a meal and seems to have a significant effect on glucose levels. Our current PharmD candidate, Farhan Guard, from Lake Erie College of Medicine, found out about this …

Read More »

Letter from the Editor #582

The National Committee for Quality Assurance (NCQA) recently held a series of webinars to help clinicians in “Achieving and Outperforming Type 2 Diabetes HEDIS Measures.“ There were a lot of elements that needed to fall into place to make that happen and our Pharm D candidate, Daniel Schultz, listened in …

Read More »

GLP-1 Special Series Editor’s Note #6

This week we get back to our interview with Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center. He has been at the forefront in developing new technologies for growing and regenerating beta cells. Our publisher, Steve Freed, had a few questions for him on how he views the use …

Read More »